Educational Event in Focus

February 6th - 2019

Our ROCKSTAR cartilage platform is a continuous evolution of how best to treat the patient who has cartilage issues. There is an array of options available, no two patients are the same which is why having multiple cartilage options is important. Even more important is understanding the range of potential solutions and when best to the deploy it.

ROCKstar 2019 looks to open up the discussion on these topics. We are also delighted to be working with the London Osteotomy Masterclass team to offer the course as an optional first day of the 2 day Osteotomy meeting which is the 7th and 8th.

Latest News

Newclip PSI Osteotomy Workshop

NEWCLIP TECHNICS ADVANCED COURSE IN OSTEOTOMY The latest in technologies for the femoral and tibial osteotomies – the use of patient specific instrumentation (PSI). Founded in 2002, NEWCLIP TECHNICS is based near Nantes, in Western France where the facility has... read more

Bristol Uni Knee Meeting

The Bristol / Oxford Uni Knee Meeting is one of the most established conferences in the Joint Preservation calendar. The meeting has expanded in recent years to address the philosophy of the modern Joint Preservation practice. In 2018, the Joint Operations portfolio... read more

Patellofemoral Masterclass, Warwick

Joint Operations is proud to have supported the fourth biennial Patella-femoral Masterclass which took place this year at Warwick university. Several of the most well renowned PFJ experts provided updates on the latest techniques and treatments for patella... read more

BOFAS, Edinburgh

Joint Operations thoroughly enjoyed this year’s BOFAS in Edinburgh. We were delighted to welcome so many delegates to our Joint Operations dinner in the National Museum of Edinburgh. Prof M. Richter presented a fascinating talk on his 10-year experience with... read more

Arthrosurface Cadaveric Lab Barcelona

Our partners Arthrosuface are world leading experts in focal cartilage resurfacing devices. Since the first HemiCAP was implanted in 2003, over 100,000 patients have received an Arthrosurface HemiCAP with many staying active passed the 10-year mark. There are over... read more

British Orthopaedic Association Annual Congress

Joint Operations were very proud to be a part of the 100th BOA Annual Congress that took place this September at the Birmingham ICC. Exhibiting alongside Parcus Medical, we met a host of new faces to discuss joint preservation techniques and technologies with. Tweets... read more

FASt Meeting, Glasgow

The FASt Meeting Friday 28thSeptember took place at the Golden Jubilee Conference centre in Glasgow. It was great to see so much discussion during the meeting around the use of the AMIC technique and Chondrogide. Mr. Hepple from University Hospital of Bristol... read more

The Principles of Bone Grafting in Wrightington

In September 2018 Joint Operations and our partners at the Wrightington Lower Limb unit organised the first ‘Principles in bone grafting workshop’ at the Cadaveric lab in Wrightington, Wigan. It was at this hospital that Sir John Charnley pioneered hip replacement... read more

The Inaugural AMIC Foot and Ankle Focus Meeting in Wolhusen, Switzerland

Foot and Ankle ROCKstar September 2018 We were delighted to welcome thirteen foot and ankle specialists from across the UK to meet in Luzern, Switzerland for the first AMIC focus group. With specialist interest in foot and ankle cartilage treatment, each surgeon... read more

The potential of fat cells – Webinar by Prof. Lee

The Magic of Fat Cells Professor Paul Lee takes us further into the exciting world of cell therapies, and explains the cellular magic behind using fat to enhance tissue repair in the knee. In this webinar Dr Paul Lee discusses the use of cells in regenerative... read more

Cell Therapy in Osteoarthritis – by Prof. Paul Lee

Joint Operations’ educational partner ‘Knee Guru’ recently hosted Prof. Paul Lee in a webinar titled ‘Cell Therapy in Osteoarthritis’ Professor Lee is double board certified in Orthopaedic surgery and Sports Medicine, he has a specialist... read more

Joint Operations becomes sole UK distributor for the mi-eye 2™ from Trice Medical

Joint Operations are delighted to have been awarded distribution rights for mi-eye 2, a revolutionary imaging solution by Trice Medical that allows surgeons to perform a full diagnostic arthroscopy in an outpatient clinic setting. The mi-eye 2 is a handheld... read more

Launch of Regen Medical, part of the Joint Operations family

We are delighted to announce the launch of Regen Medical, a new and integral part of the Joint Operations family. The dedicated Regen Medical team was formed to continue the commitment from Joint Operations to support its customers within the Burns, Wound Healing,... read more

Celebrating Coflex® on World Spine Day

On World Spine Day, Joint Operations Spine wishes to celebrate how Coflex®, an interlaminar stabilisation device with more than 20 years clinical history has changed the lives of patients in more than 40 countries worldwide, providing faster, sustained pain relief and... read more

Joint Operations Awarded UK Distributorship for FH Orthopedics ESP Artificial Disc Range

Joint Operations LLP announce their partnership with FH Orthopedics as UK distributors of the ESP lumbar and cervical disc range. The collaboration with FH Orthopedics further cements Joint Operations position within the spinal device market as offering innovative... read more

Highlights from the inaugural ROCKSTAR Kongress

The 27th and 28th June 2017 saw the introduction of a new event on the Orthopaedic calendar. The inaugural ROCKSTAR Kongress, an event hosted by Joint Operations and aimed at Orthopaedic consultants with an interest in Regenerative Medicine and the treatment of... read more

Joint Operations launches new Spine division partnering with global motion preservation market leader Paradigm Spine

Joint Operations is delighted to announce it’s partnership with Paradigm Spine, becoming exclusive UK distributor of their spinal product range. These products are the first to be introduced into the new Joint Operations Spine division product portfolio.... read more

Coming Soon…….

We have not yet published a new article about this meeting. You can read our previous news feeds here – News You can also follow our Events timeline, Twitter, Linkedin and Youtube to keep up to date with all of our exciting upcoming events! Come and visit our... read more

Successfully matching Meniscal Allograft for transplant

Mr Thompson who recently chaired day two of the ROCKSTAR event focusing on cartilage regeneration, is a Consultant Orthopaedic Surgeon, based in the Midlands and specialising exclusively in knee surgery and sports injuries of the lower limb. Mr Thompson has numerous... read more

Sorry you’ve missed us!

Keep up to date with our Events timeline, Twitter, Linkedin and Youtube to find out about all of the exciting upcoming Joint Operations events! Come and visit our stand at exhibitions Meet us at conferences and meetings Attend surgical training workshops Join our... read more

Joint Operations represents U.S. market leading HA injectable

We are delighted to announce the addition of Anika Therapeutics’ range of products to our joint preservation portfolio. This U.S. market-leading range offers a safe and well established treatment to patients and health care professionals alike, providing pain relief... read more

Joint Operations awarded UK distribution rights for Lipogems

Joint Operations is delighted to have been awarded UK distribution rights for Lipogems. Lipogems is a unique system intended for the harvesting of adipose tissue and the closed-loop processing and transferring of autologous tissue. This non-expanded and... read more

Unleash your inner Rockstar during this new event on the Orthopaedic Calendar

Joint Operations and Lipogems are delighted to announce the ROCKSTAR Meeting 2017. This new event will provide UK Orthopaedic Consultants, Registrars & Fellows with the opportunity to discuss new developments in regenerative medicine within Orthopaedics, and to... read more

What Makes A Good Orthopaedic Conference?

Joint Operations recently spoke with David Penford at Clockwork Marketing and Events to discuss what makes a successful Orthopaedic conference. With over 25 years’ experience in planning and delivering successful conferences, David and his team are well versed... read more

Acellular Dermal Allograft – Key facts on biocompatibility and growth factors that make for an ideal scaffold

Allograft (Human) Acellular Dermal Matrix represents a viable option in both tissue replacement and reconstruction. The following article looks at two publications from the AlloSource Basic Science series. Acellular dermal matrices can be used to successfully replace... read more

If Something Is To Grow, It Has To Change: The NHS Five Year Forward View

Welcome to our latest series of short articles on the world of the NHS and medical devices. As part of ongoing NHS reform, the Five Year Forward View (5YFV) attempts the most radical approach yet. Here, we give an overview of its main themes and initiatives. What’s... read more

Sales & Stereotypes: The ‘Ultimate’ Medical Sales Professional?

Welcome to our latest series of short articles on the world of the NHS and medical devices. Healthcare teamwork comprises many different professionals and personalities. Here, we take a look at the role of the medical sales representative. What qualities would your... read more

Joint Operations lends support to Swindon’s Christmas Care project

Joint Operations are proud to be supporting Christmas Care this festive season. Christmas Care is based in Swindon, at Buckhurst Park Community Centre, and will be open 24 hours a day from Christmas Eve until the morning of 28th December. The project will provide... read more

The NHS: The Reason It Works So Well – The Art of Theatre: Lights, Scalpel, Action…

Welcome to the second instalment in our series of three short articles on the NHS. As a medical distributor, we’re in the privileged position of working alongside the people who make it happen. Here’s a further take on why it works so well –... read more

The NHS: The Reason It Works So Well – Celebrating an Impossible Equation and an Undeniable Truism

Welcome to a series of short articles on the NHS. As a medical device distributor, we’re in the privileged position of working alongside the people who make it happen. Here’s our take on why it works so well… The NHS is widely considered a remarkable... read more

The roulette table of stem cell therapy, don’t take a chance on a spinning

The regenerative qualities of bone marrow have been used for decades and are considered the gold standard for stem cell harvesting. However, after the first 1-2 mL of bone marrow aspirate from a traditional needle, the number of total nucleated cells (TNC) in the... read more

5 reasons to change what you do with Burn Care skin

Cryopreserved burn care skin is normally reserved for larger burns. Working with our partners AlloSource we have found ways to help make the GOLD STANDARD in burn care more accessible, not just for larger burns but for use in smaller burns too. As one of the... read more

Size matters… When it comes to choosing the right allograft match

Every Orthopaedic procedure requires close co-ordination between clinicians, hospital management and the supplier. With allografts this partnership is pivotal to bring about a successful patient outcome as accurate size matching is one of the key components for... read more

Joint Operations attending the first Educational Course of the European Burns Association

Joint Operations are proud to be attending EBA 2016, the first show of this kind. Over the course of the show, we will be exhibiting a number of innovative and unique products within the fields of Burns, Plastics and Reconstruction. Our unique and wide range includes... read more

Joint Operations welcomes two local Apprentices

The last few months have seen many exciting developments at Joint Operations, a Swindon based medical device distribution business focussing on Joint Preservation, Extremities and Regenerative Medicine. June saw the 1st birthday celebration of the company’s... read more

Patellofemoral Disease – Inlay vs Onlay?

A recent paper by Andreas Imhoff comparing the inlay Arthrosurface Wave to the onlay Smith & Nephew Journey implant shows a reduction in OA progression with the inlayed Wave design. The authors suggest that this may be due to the more anatomic nature of the... read more

Joint preservation and the challenge of healthcare economics

With patients remaining active later in life and with life expectancy itself extending, Joint Preservation of the knee has become an orthopaedic sub-speciality in its own right. Understandably, how to fund this treatment has lead to a meaningful debate within NHS... read more

The Effect of Different Bone Marrow Stimulation Techniques on Human Bone

Microfracture has been used for many years as a first line treatment for smaller cartilage defects. Traditionally a 2mm Steadman awl or 2mm K Wire is used to create a channel from the defect site into the subchondral bone below through which stem cells flow to form a... read more

Regenerating Cartilage Techniques in the big toe in early stage Hallux Rigidus patients with AMIC

Treating Cartilage defects is a hot topic within Orthopaedics and there are many ways to approach this, including a variety of treatment options. One thing is universally agreed; Mesenchymal stem cells need to be present to begin the delicate process of building new... read more

Regenerative Medicine – The Future of Plastic Surgery

What is regenerative medicine? Regenerative medicine is the science of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal form and function. This broadly encompasses the use of cells, tissues, drugs, synthetic... read more

AlloSource® Announces Positive Clinical Results For AlloTrue™- In Kaiser Permanente Study Of ACL Revision Risks

Richard Forster, founder of Joint Operations has a long standing working relationship with Allosource and their sister company JRF. Together they have overseen the supply of their Allografts in the UK for a number of years. This recent paper highlights a number... read more

HTA licence approved for Joint Operations

HTA licence approved for Joint Operations. Joint Operations operates in several specialities which utilise human tissue for repair and regeneration. Primarily these include Orthopaedics, Burns and Plastics and Cardio Thoracic surgery. As such we are excited to... read more

ALLOSOURCE’S NEW CARTILAGE REPAIR PRODUCT, PROCHONDRIX, RECEIVES PATENT

For more information Click here Centennial, Colo. — January 19, 2016 — AlloSource®, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, was... read more

Tweets by JO_SaveTheJoint